The nation’s medical-device makers and drug companies will begin collecting this week what is expected to become a massive stockpile of data on their financial relationships with doctors, researchers and teaching hospitals.
For doctors and med firms, a new era of disclosure
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.